LCM
PRME icon

Laurion Capital Management’s Prime Medicine PRME Stock Holding History

Laurion Capital Management’s Portfolio PRME Stock Details PRME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-55,888
Closed -$819K – 639
2023
Q2 		$819K Sell
55,888
-4,112
-7% -$57.4K ﹤0.01% 385
2023
Q1 		$738K Hold
60,000
– – 0.01% 316
2022
Q4 		$1.11M Buy
+60,000
New +$1.08M 0.01% 327

Other funds holding PRME

AI
Alphabet Inc Mountain View, California $4.02B AUM 215.74% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
MM
MWG Management Road Town, Tortola, British Virgin Islands $81.3M AUM 2.28% 1-Year Est. Return

Laurion Capital Management's PRME Position: Q3 2023 in Review

Laurion Capital Management sold out of Prime Medicine (PRME) in Q3 2023, closing a stake of 55,888 shares — an estimated $819K sold.

Laurion Capital Management first reported a position in PRME in Q4 2022 and held it in 3 quarters. The position peaked at $1.11M in Q4 2022. 83 funds tracked by Wall St. Rank hold PRME as of Q3 2023.

  • Laurion Capital Management reported no remaining Prime Medicine position as of Q3 2023 after selling out during the quarter.
  • Laurion Capital Management sold 55,888 Prime Medicine shares in Q3 2023, an estimated $819K.
  • Laurion Capital Management first reported a position in Prime Medicine in Q4 2022 and held it in 3 quarters.
  • Laurion Capital Management's Prime Medicine position peaked at $1.11M in Q4 2022.
  • 83 funds tracked by Wall St. Rank held Prime Medicine as of Q3 2023.

Based on Laurion Capital Management's 13F filing for Q3 2023, filed 14 Nov 2023.